Table II.
Characteristics of clinical isolates.
| Clinical isolate | Source of infection | Antibiotic resistance |
|---|---|---|
| Staphylococcus epidermidis 146 | Corneal ulcer | Oxacillin, ofloxacin, tobramycin, cefalotin, ceftriaxone, sulfisoxazole |
| Staphylococcus epidermidis 144 | Corneal ulcer | Neomycin, gentamicin, ceftazidime, ceftriaxone, tetracycline, sulfisoxazole |
| Staphylococcus epidermidis 199 | Corneal ulcer | Norfloxacin, ceftazidime, ceftriaxone, polymyxin B, sulfisoxazole |
| Staphylococcus epidermidis 2022 | Corneal ulcer | Gentamicin, ceftazidime, ceftriaxone, tetracycline, sulfisoxazole |
| Staphylococcus epidermidis 1654 | Corneal ulcer | Norfloxacin, ceftazidime, ceftriaxone |
| Staphylococcus epidermidis 2050 | Conjunctivitis | Ofloxacin, tobramycin, gentamicin, norfloxacin, cefalotin, ceftazidime, tetracycline, sulfisoxazole |
| Staphylococcus epidermidis 2038 | Endophthalmitis | Oxacillin, tobramycin, gentamicin, ceftazidime, ceftriaxone, tetracycline |
| Staphylococcus epidermidis 63 | Endophthalmitis | Ofloxacin, tobramycin, gentamicin, norfloxacin, ceftazidime, ceftriaxone, polymyxin B, tetracycline, sulfisoxazole |
| Staphylococcus epidermidis 112IP | Hip | Oxacillin, gentamicin, ciprofloxacin, levofloxacin, moxifloxacin, rifampin, trimethoprim-sulfamethoxazole |
| Staphylococcus epidermidis 675IP | Knee | Oxacillin, gentamicin, ciprofloxacin, levofloxacin, moxifloxacin, tetracycline, rifampin, trimethoprim-sulfamethoxazole |
| Staphylococcus epidermidis 085IP | Hip | Oxacillin, gentamicin, ciprofloxacin, levofloxacin, moxifloxacin, tetracycline |
| Staphylococcus epidermidis 1302IP | Hip | Oxacillin, gentamicin, ciprofloxacin, levofloxacin, moxifloxacin, erythromycin, clindamycin |
| Staphylococcus epidermidis 583IP | Hip | Oxacillin, gentamicin, ciprofloxacin, levofloxacin, moxifloxacin, tetracycline, trimethoprim-sulfamethoxazole |
| Staphylococcus epidermidis 563IP | Hip | Oxacillin, gentamicin, ciprofloxacin, levofloxacin, moxifloxacin, tetracycline, trimethoprim-sulfamethoxazole |
| Staphylococcus epidermidis 536IP | Hip | Oxacillin, ciprofloxacin, levofloxacin, moxifloxacin, clindamycin |
| Staphylococcus epidermidis 274IP | Hip | Oxacillin, ciprofloxacin, levofloxacin, moxifloxacin |
| Staphylococcus epidermidis 587IP | Hip | Oxacillin, gentamicin, ciprofloxacin, levofloxacin, moxifloxacin, erythromycin, clindamycin |
| Staphylococcus epidermidis 848IP | Hip | Oxacillin, gentamicin, ciprofloxacin, levofloxacin, moxifloxacin |
| Klebsiella pneumoniae | Urine sample | Ceftazidime, ceftriaxone, cefepime, doripenem, etapenem, meropenem, |
| imipenem, amikacin, gentamicin, ciprofloxacin, rifamycin | ||
| Enterobacter cloacae | Wound infection | Ceftazidime, ceftriaxone, cefepime, doripenem, etapenem, meropenem, imipenem, amikacin, gentamicin, ciprofloxacin, rifamycin |
| Acinetobacter baumannii | Blood sample | Piperaciline, ceftazidime, ceftriaxone, cefepime, doripenem, etapenem, meropenem, imipenem, amikacin, gentamicin, ciprofloxacin, rifamycin |
| Pseudomonas aeruginosa | Blood sample | Piperaciline, ceftazidime, ceftriaxone, cefepime, doripenem, etapenem, meropenem, imipenem, amikacin, gentamicin, ciprofloxacin, rifamycin |
| Staphylococcus aureus | Wound infection | Oxacillin, gentamicin, ciprofloxacin, erythromycin, clindamycin, tetracycline, trimethoprim-sulfamethoxazole, penicillin, rifamycin |
| Enterococcus faecium | Urine sample | Erythromycin, clindamycin, tetracycline, penicillin, rifamycin |